mocravimod

Leah SherwoodAcute Myeloid Leukemia | November 14, 2022
Mocravimod is a synthetic, sphingosine 1-phosphate receptor modulator that has been assessed in phase I and II trials.
Leah LawrenceAcute Myeloid Leukemia | February 2, 2023
Mocravimod is a synthetic, sphingosine 1-phosphate receptor (S1PR) modulator.
Advertisement
Advertisement
Advertisement
Advertisement